Catalyst Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Catalyst Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Catalyst Pharmaceuticals Inc
Rating: 2.049527875
Author: Trendlyne DVM scores

Momentum Trap

about

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Com...

24.69 -0.13 (-0.52%)

29.61% Gain from 52W Low

616.1K

XNAS Volume

XNAS 02 Apr, 2026 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Mid Valuation

46.7 / 100

Technically Moderately Bullish

61.7 / 100

Momentum Trap These stocks have average financials but are currently seeing momentum. Investors should exercise caution in buying these stocks View Similar Embed DVM

1Yr Price target upside is 38%

7 analysts

Catalyst Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Catalyst Pharma Inc Live Stock Price Today, Share Analysis and Chart

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Com...

29.61% Gain from 52W Low

SWOT Analysis

Catalyst Pharma Inc Live Price Chart